OQROGet OQRO Pro
Insider trade

Medtronic (MDT)Director bought ~$232K

William R Jellison, Director at Medtronic, bought ~$232K of Medtronic shares.

~$232K
Approx. value · 2,500 sh @ $92.73
2,500
Holds after · shares reported
Traded
Aug 22, 2025
Filed
Aug 25, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. Aug 14, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  3. Aug 22, 2025 · this disclosureInsiderDirector purchased ~$232K of MDT shares in the open market

What came next

  1. Aug 25, 2025InsiderDirector purchased ~$231K of MDT shares in the open market
  2. Sep 3, 2025Insider · 1 personInsiders: 2 sales (~$788K)
  3. Sep 29, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  4. Oct 16, 2025Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  5. Oct 20, 2025FDARecall: Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03
  6. Oct 21, 2025FDARecall: CareLink Clinic, REF: MMT-7350
  7. Oct 24, 2025FDAFDA device clearance: Parietene™ Flat Sheet Mesh
  8. Oct 24, 2025FDAFDA device clearance: Infinity™ OCT System
  9. Oct 24, 2025FDAFDA device clearance: CD Horizon™ Spinal System
  10. Oct 29, 2025FDAFDA device clearance: Telescope Guide Extension Catheter
  11. Oct 29, 2025FDARecall: Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable cardioverter defibrillators (ICD), Product Number DVEA3E4
  12. Nov 1, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 1, 2025, Gregory L. Smith, Executive Vice President, Enterprise Operations of Medtronic plc (the Company), notified the Company of his decision to retire from the Company, effective December 2, 2025, and to join a private equity-held organization.”
  13. Nov 2, 2025FDARecall: MiniMed 780G Insulin Pump Catalog Numbers: MMT-1884 MMT-1886 With Software Version 6.60 The MiniMed 780G insulin pump is indicated for use by patients age 7-80…
  14. Nov 5, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  15. Nov 13, 2025FDARecall: InPen App, Model/CFN Number: MMT-8061 (Android Users)
  16. Nov 13, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  17. Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
  18. Nov 19, 2025Insider · 1 personInsiders: 7 sales (~$3.1M)
  19. Nov 20, 2025FDARecall: Restore Clinician Programmer Application (CP App), Model A71100 used with the following programmers: CT900A PROG CT900A CLINICIAN TABLET US CT900B PROG CT900B…
  20. Dec 3, 2025FDAFDA device clearance: Hugo™ RAS System
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by William R Jellison, Director

The full history of William R Jellison, Director is on the profile page.

How this filing works

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data